Biological Mediator-Propelled Nanosweeper for Nonpharmaceutical Thrombus Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33724000.
- Also identified by DOI 10.1021/acsnano.0c09939.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Traditional thrombolytic drugs offer limited outcomes due to short circulation half-life and low utilization. Herein, we have designed and constructed a biological mediator-propelled nanosweeper for highly efficient nonpharmaceutical thrombolysis and prevention of thrombus recurrence. Under the near-infrared light irradiation, the nanosweepers were activated to trigger nitric oxide (NO) release, which propelled the nanosweepers to penetrate deeply into the thrombus and resulted in enhanced site-pecific mechanical and photothermal thrombolysis. The experimental evidence confirmed that the ingenious nanosweeper displayed excellent site-specific thrombolytic efficacy even when compared with the clinical thrombolytic drug. In the meantime, as a biological mediator, the release of NO could effectively prevent thrombus recurrence <i>in vivo</i>. Overall, we anticipated that the nanosweeper would provide a promising strategy for the treatment of thrombi.
Medical subject headings
- Thrombolytic Therapy
- Thrombosis